How has been the historical performance of Zydus Lifesci.?

Answer:The historical performance of Zydus Lifesci shows a consistent growth trend in net sales and profits over the years, with significant increases noted in the most recent fiscal year ending March 2025.

Breakdown:
Zydus Lifesci's net sales have risen from 14,253.10 Cr in March 2020 to 23,241.50 Cr in March 2025, reflecting a strong upward trajectory. Total operating income followed a similar trend, increasing from 14,253.10 Cr in March 2020 to 23,241.50 Cr in March 2025. The company's operating profit (PBDIT) also saw substantial growth, climbing from 2,783.40 Cr in March 2020 to 7,328.00 Cr in March 2025, indicating improved operational efficiency. Profit before tax surged from 1,495.40 Cr in March 2020 to 6,026.70 Cr in March 2025, while profit after tax increased from 1,175.60 Cr to 4,614.80 Cr during the same period. The earnings per share (EPS) rose significantly from 11.49 in March 2020 to 44.99 in March 2025, showcasing enhanced shareholder value. On the balance sheet, total assets grew from 22,833.70 Cr in March 2020 to 34,857.90 Cr in March 2025, while total liabilities decreased from 7,901.10 Cr to 0.00 Cr, indicating a strong financial position with no debt. Cash flow from operating activities improved markedly, reaching 6,776.00 Cr in March 2025, compared to 2,931.00 Cr in March 2020, further highlighting the company's robust cash generation capabilities. Overall, Zydus Lifesci has demonstrated impressive growth in revenue, profitability, and financial stability over the historical period analyzed.